Company Notes
|
|
Notes to the Group Annual Financial Statements
for the year ended 30 June 2011 |
|
|
| |
| |
Continuing operations |
Discontinued operations |
Total |
| |
|
|
2011
R’million |
|
Restated
2010
R’million |
2011
R’million |
|
Restated
2010
R’million |
2011
R’million |
|
2010
R’million |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| 26. |
DIRECTORS AND EMPLOYEES |
|
|
|
|
|
|
|
|
|
|
|
| |
Staff costs |
|
|
|
|
|
|
|
|
|
|
|
| |
Wages and salaries |
|
1 532,8 |
|
1 216,9 |
18,9 |
|
13,2 |
1 551,7 |
|
1 230,1 |
|
| |
Provident fund contributions – defined contribution plans |
|
113,2 |
|
86,2 |
– |
|
– |
113,2 |
|
86,2 |
|
| |
Medical aid contributions |
|
61,5 |
|
55,0 |
– |
|
– |
61,5 |
|
55,0 |
|
| |
Retirement benefit obligations |
|
3,4 |
|
2,1 |
– |
|
– |
3,4 |
|
2,1 |
|
| |
Other long-term benefits |
|
0,4 |
|
0,4 |
– |
|
– |
0,4 |
|
0,4 |
|
| |
Termination benefits |
|
12,8 |
|
12,1 |
– |
|
– |
12,8 |
|
12,1 |
|
| |
Share-based payment expense – options and appreciation rights |
|
14,1 |
|
22,1 |
– |
|
– |
14,1 |
|
22,1 |
|
| |
Share-based payment expense – Workers’ Share Plan |
|
– |
|
0,9 |
– |
|
– |
– |
|
0,9 |
|
| |
Share-based payment expense – deferred incentive bonus |
|
15,7 |
|
6,8 |
– |
|
– |
15,7 |
|
6,8 |
|
| |
Share-based payment expense – phantom share scheme |
|
0,8 |
|
– |
– |
|
– |
0,8 |
|
– |
|
| |
Other company contributions |
|
29,6 |
|
32,1 |
– |
|
– |
29,6 |
|
32,1 |
|
| |
|
|
1 784,3 |
|
1 434,6 |
18,9 |
|
13,2 |
1 803,2 |
|
1 447,8 |
|
| |
Amount included in cost of sales |
|
945,6 |
|
768,7 |
– |
|
– |
945,6 |
|
768,7 |
|
| |
Wages and salaries |
|
846,2 |
|
679,6 |
– |
|
– |
846,2 |
|
679,6 |
|
| |
Benefits |
|
99,4 |
|
89,1 |
– |
|
– |
99,4 |
|
89,1 |
|
| |
Amount included in selling and distribution expenses |
|
422,6 |
|
290,5 |
– |
|
– |
422,6 |
|
290,5 |
|
| |
Wages and salaries |
|
343,4 |
|
228,4 |
– |
|
– |
343,4 |
|
228,4 |
|
| |
Benefits |
|
79,2 |
|
62,1 |
– |
|
– |
79,2 |
|
62,1 |
|
| |
Amount included in administrative expenses |
|
416,1 |
|
375,4 |
18,9 |
|
13,2 |
435,0 |
|
388,6 |
|
| |
Wages and salaries |
|
343,0 |
|
308,9 |
18,9 |
|
13,2 |
361,9 |
|
322,1 |
|
| |
Benefits |
|
73,1 |
|
66,5 |
– |
|
– |
73,1 |
|
66,5 |
|
| |
Total number of employees at year-end |
|
6 319 |
|
6 067 |
–# |
|
–# |
6 319 |
|
6 067 |
|
| |
Full-time employees |
|
5 168 |
|
4 583 |
– |
|
– |
5 168 |
|
4 583 |
|
| |
Part-time employees |
|
1 151 |
|
1 484 |
– |
|
– |
1 151 |
|
1 484 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
# |
The total number of employees for discontinued operations has not been disclosed as they were not deemed as part of the total number of employees at year-end. |
| |
Directors’ emoluments and prescribed officers |
| |
|
Fees
R’million |
Remune-
ration
R’million |
Retirement
and medical
aid benefits
R’million |
Performance
bonus
R’million |
Share
expenses*
R’million |
Total
R’million |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
2011 |
|
|
|
|
|
|
|
| |
Non-executive directors |
|
|
|
|
|
|
|
| |
Archie Aaron |
0,1 |
– |
– |
– |
– |
0,1 |
|
| |
Roy Andersen |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
Rafique Bagus |
0,4 |
– |
– |
– |
– |
0,4 |
|
| |
John Buchanan |
0,5 |
– |
– |
– |
– |
0,5 |
|
| |
Judy Dlamini |
0,7 |
– |
– |
– |
– |
0,7 |
|
| |
Abbas Hussain |
0,1 |
– |
– |
– |
– |
0,1 |
|
| |
Chris Mortimer |
0,2 |
– |
– |
– |
– |
0,2 |
|
| |
David Nurek |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
Sindi Zilwa |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
Total (A) |
2,9 |
– |
– |
– |
– |
2,9 |
|
| |
Executive directors |
|
|
|
|
|
|
|
| |
Gus Attridge |
– |
3,9 |
0,5 |
4,3 |
2,1 |
10,8 |
|
| |
Stephen Saad |
– |
4,7 |
0,6 |
5,2 |
2,6 |
13,1 |
|
| |
Total (B) |
– |
8,6 |
1,1 |
9,5 |
4,7 |
23,9 |
|
| |
Prescribed officers |
|
|
|
|
|
|
|
| |
Morné Geyser |
– |
1,8 |
0,3 |
0,5 |
3,6 |
6,2 |
|
| |
Noel Guliwe |
– |
2,5 |
0,4 |
0,7 |
0,8 |
4,4 |
|
| |
Total (C) |
– |
4,2 |
0,7 |
1,2 |
4,4 |
10,6 |
|
| |
Total emoluments (A+B+C) |
|
|
|
|
|
37,4 |
|
| |
Less paid by subsidiary companies (D) |
|
|
|
|
|
15,0 |
|
| |
Total emoluments paid by Aspen (A+B+C-D) |
|
|
|
|
|
22,4 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
2010 |
|
|
|
|
|
|
|
| |
Non-executive directors |
|
|
|
|
|
|
|
| |
Archie Aaron |
0,2 |
– |
– |
– |
– |
0,2 |
|
| |
Roy Andersen |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
Rafique Bagus |
0,2 |
– |
– |
– |
– |
0,2 |
|
| |
John Buchanan |
0,5 |
– |
– |
– |
– |
0,5 |
|
| |
Judy Dlamini |
0,6 |
– |
– |
– |
– |
0,6 |
|
| |
Abbas Hussain |
0,1 |
– |
– |
– |
– |
0,1 |
|
| |
Chris Mortimer |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
David Nurek |
0,2 |
– |
– |
– |
– |
0,2 |
|
| |
Sindi Zilwa |
0,3 |
– |
– |
– |
– |
0,3 |
|
| |
Total (A) |
2,7 |
– |
– |
– |
– |
2,7 |
|
| |
Executive directors |
|
|
|
|
|
|
|
| |
Gus Attridge |
– |
3,6 |
0,5 |
4,1 |
1,8 |
10,0 |
|
| |
Stephen Saad |
– |
4,4 |
0,5 |
5,0 |
2,1 |
12,0 |
|
| |
Total (B) |
– |
8,0 |
1,0 |
9,1 |
3,9 |
22,0 |
|
| |
Prescribed officers |
|
|
|
|
|
|
|
| |
Morné Geyser |
– |
1,4 |
0,2 |
0,5 |
0,3 |
2,4 |
|
| |
Noel Guliwe |
– |
2,3 |
0,4 |
0,7 |
0,4 |
3,8 |
|
| |
Total (C) |
– |
3,7 |
0,6 |
1,2 |
0,7 |
6,2 |
|
| |
Total emoluments
(A+B+C) |
|
|
|
|
|
30,9 |
|
| |
Less paid by subsidiary companies (D) |
|
|
|
|
|
10,7 |
|
| |
Total emoluments paid by Aspen (A+B+C-D) |
|
|
|
|
|
20,2 |
|
| |
* |
This includes both the IFRS 2 share-based payment expense as well as gains made on the exercise of share options and/or share appreciation rights. |
|
|
|